Header Logo

Connection

IRINA AGOULNIK to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications IRINA AGOULNIK has written about Combined Modality Therapy.
IRINA AGOULNIK
Connection Strength
0.007
Combined Modality Therapy
  1. Adenovirus mediated thymidine kinase gene therapy may enhance sensitivity of ovarian cancer cells to chemotherapeutic agents. Anticancer Res. 1998 Sep-Oct; 18(5A):3421-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.